Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SENS | US
0.05
0.71%
Healthcare
Diagnostics & Research
30/06/2024
24/04/2026
7.05
7.07
7.28
7.02
Senseonics Holdings Inc. a medical technology company develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States Europe the Middle East and Africa. The company's products include Eversense Eversense XL and Eversense E3 which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor a removable and rechargeable smart transmitter and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings Inc. was founded in 1996 and is headquartered in Germantown Maryland.
View LessPositive Momentum
Strength based on increasing price with high volume
Low Market Beta (-0.4 to 0.8)
Strong Revenue Growth (> 10%)
High 6-Month Volatility (>65%)
Midcap (2B - 10B USD)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
6.3%1 month
37.1%3 months
76.3%6 months
70.7%-
21.51
329.13
1.55
0.53
1.76
6.86
-
-72.41M
3.78B
3.78B
-
-400.68
-
17.90
-125.30
7.51
10.03
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.71
Range1M
1.11
Range3M
3.43
Rel. volume
1.47
Price X volume
3.00M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Twist Bioscience Corporation | TWST | Diagnostics & Research | 60.94 | 3.57B | 3.55% | n/a | 17.75% |
| Neogen Corporation | NEOG | Diagnostics & Research | 9.54 | 2.07B | 2.03% | n/a | 28.45% |
| Soleno Therapeutics Inc | SLNO | Diagnostics & Research | 52.72 | 2.05B | -0.21% | n/a | 0.11% |
| Biodesix Inc | BDSX | Diagnostics & Research | 10.64 | 1.54B | 6.83% | n/a | 169.94% |
| CareDx Inc | CDNA | Diagnostics & Research | 21.23 | 1.12B | 5.83% | n/a | 11.88% |
| NeoGenomics Inc | NEO | Diagnostics & Research | 8.29 | 1.06B | 4.80% | n/a | 66.22% |
| Check-Cap Ltd | CHEK | Diagnostics & Research | 138 | 807.19M | -2.82% | n/a | 0.00% |
| Quidel Corporation | QDEL | Diagnostics & Research | 11.59 | 779.26M | 3.11% | n/a | 87.31% |
| Atossa Genetics Inc | ATOS | Diagnostics & Research | 5.7 | 716.81M | -0.52% | n/a | 0.00% |
| CASTLE BIOSCIENCES INC | CSTL | Diagnostics & Research | 24.46 | 678.44M | 3.25% | n/a | 5.94% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Cinemark Holdings Inc | CNK | Media - Diversified | 28.48 | 3.49B | -0.42% | 27.93 | 934.91% |
| VeriFone Systems Inc | PAY | Building Products & Equipment | 27.25 | 3.39B | 0.96% | 102.46 | 2.10% |
| Polaris Industries Inc | PII | Recreational Vehicles | 60.04 | 3.35B | 1.06% | 14.48 | 170.51% |
| LCI Industries | LCII | Recreational Vehicles | 120.01 | 3.06B | -0.45% | 25.82 | 77.66% |
| Harley-Davidson Inc | HOG | Recreational Vehicles | 23.11 | 3.04B | -1.15% | 7.33 | 218.58% |
| Pitney Bowes Inc | PBI | Building Products & Equipment | 15.58 | 2.80B | 1.37% | n/a | -571.93% |
| IMAX Corporation | IMAX | Media - Diversified | 36.45 | 1.92B | -0.44% | 54.26 | 110.44% |
| HNI Corporation | HNI | Building Products & Equipment | 37.7 | 1.78B | 1.32% | 22.12 | 76.47% |
| ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 14.6 | 1.46B | 3.03% | n/a | 19.46% |
| Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 39.11 | 1.23B | -1.21% | 51.60 | 88.92% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 1.76 | 12.67 | Cheaper |
| Ent. to Revenue | 6.86 | 44.00 | Cheaper |
| PE Ratio | - | 40.09 | - |
| Price to Book | 329.13 | 77.50 | Expensive |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 76.28 | 59.59 | Riskier |
| Debt to Equity | 1.55 | -14.36 | Expensive |
| Debt to Assets | 0.53 | 0.34 | Expensive |
| Market Cap | 3.78B | 13.71B | Emerging |